REKOVA, Petra, Gabriela DOSTALOVA, David KEMLINK, Jaroslava SCHWABOVA PAULASOVA, Zora DUBSKA, Manuela VANECKOVA, Martin MASEK, Ondrej KODET, Helena POUPETOVA, Stella MAZUROVA, Aneta RAJDOVÁ, Eva VLČKOVÁ, Alena TABORIKOVA, Stepanka FAFEJTOVA, Miroslava NEVSIMALOVA, Ales LINHART and Ales TOMEK. Detailed Phenotype of GLA Variants Identified by the Nationwide Neurological Screening of Stroke Patients in the Czech Republic. Journal of Clinical Medicine. Basel: MDPI, 2021, vol. 10, No 16, p. 1-17. ISSN 2077-0383. Available from: https://dx.doi.org/10.3390/jcm10163543.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Detailed Phenotype of GLA Variants Identified by the Nationwide Neurological Screening of Stroke Patients in the Czech Republic
Authors REKOVA, Petra (203 Czech Republic), Gabriela DOSTALOVA (203 Czech Republic), David KEMLINK (203 Czech Republic, guarantor), Jaroslava SCHWABOVA PAULASOVA (203 Czech Republic), Zora DUBSKA (203 Czech Republic), Manuela VANECKOVA (203 Czech Republic), Martin MASEK (203 Czech Republic), Ondrej KODET (203 Czech Republic), Helena POUPETOVA (203 Czech Republic), Stella MAZUROVA (203 Czech Republic), Aneta RAJDOVÁ (203 Czech Republic, belonging to the institution), Eva VLČKOVÁ (203 Czech Republic, belonging to the institution), Alena TABORIKOVA (203 Czech Republic), Stepanka FAFEJTOVA (203 Czech Republic), Miroslava NEVSIMALOVA (203 Czech Republic), Ales LINHART (203 Czech Republic) and Ales TOMEK (203 Czech Republic).
Edition Journal of Clinical Medicine, Basel, MDPI, 2021, 2077-0383.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30218 General and internal medicine
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.964
RIV identification code RIV/00216224:14110/21:00123211
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/jcm10163543
UT WoS 000690449900001
Keywords in English Fabry disease; GLA gene variants; phenotype; stroke; screening programs; data sharing
Tags 14110221, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 10/12/2021 14:39.
Abstract
Fabry disease (FD) is a rare X-linked disorder of glycosphingolipid metabolism caused by pathogenic variants within the alpha-galactosidase A (GLA) gene, often leading to neurological manifestations including stroke. Multiple screening programs seeking GLA variants among stroke survivors lacked detailed phenotype description, making the interpretation of the detected variant's pathogenicity difficult. Here, we describe detailed clinical characteristics of GLA variant carriers identified by a nationwide stroke screening program in the Czech Republic. A total of 23 individuals with 8 different GLA variants were included in the study. A comprehensive diagnostic workup was performed by a team of FD specialists. The investigation led to the suggestion of phenotype reclassification for the G325S mutation from late-onset to classical. A novel variant R30K was found and was classified as a variant of unknown significance (VUS). The typical manifestation in our FD patients was a stroke occurring in the posterior circulation with an accompanying pathological finding in the cerebrospinal fluid. Moreover, we confirmed that cornea verticillata is typically associated with classical variants. Our findings underline the importance of detailed phenotype description and data sharing in the correct identification of pathogenicity of gene variants detected by high-risk-population screening programs.
PrintDisplayed: 11/5/2024 22:57